1) thrombus density
血栓密度
2) Microvessel density
血管密度
1.
Relationship between microvessel density in lung cancer and clinical pathological features;
肺癌间质血管密度及临床意义
2.
Objective To study the features of redox factor-1/apurinic endonuclease (Ref-1/APE) expression and its correlation with vascular endothelial growth factor (VEGF) expression and microvessel density (MVD) in colorectal cancer (CRC).
目的探讨大肠癌氧化还原因子-1(redoxfactor-1,Ref-1),又称脱嘌呤/脱嘧啶核酸内切酶(apurinic/apyri-midinicendonuclease,APE),在大肠癌的表达特点及其与血管内皮生长因子(vascularendothelialgrowthfactor,VEGF)和血管密度的关系。
3.
Microvessel density (MVD) of human gastric carcinoma was also determined with anti-CD34 as the labelled vascular endothelial cells.
方法 采用免疫组化S P法检测 50例原发性胃癌组织、癌周组织及 2 0例正常胃黏膜组织中iNOS的表达 ,同时检测微血管密度 (MVD) ,以抗CD3 4标记血管内皮细胞 ,并分析其与肿瘤行为之间的关系。
3) MVD
血管密度
1.
Observe the bone forming area, micro vessel density(MVD),and proliferating cell nuclear antigen(PCNA index)in unit area of all the test groups.
B ,9实验单位置入自体骨 ,分别于 3周、6周、12周观察不同组别单位面积内的成骨面积、血管密度 (MVD)、间质细胞增殖指数 (PCNA增殖指数 )。
5) microvessel density (MVD)
血管密度
1.
Objective To investigate the expression of vascular endothelial growth factor (VEGF) and microvessel density (MVD) in colorectal carcinoma and their relationships with the invasiveness and metastasis of human colorectal carcinoma.
目的 探讨血管内皮细胞生长因子 (vascularendothelialgrowthfactor,VEGF)及微血管密度 (micorvesseldensity ,MVD)与大肠癌浸润、转移之间的关系。
2.
Objective To explore the correlation between microvessel density (MVD) and biological behaviors of hepatocellular carcinoma (HCC).
目的 探讨原发性肝癌中微血管密度 (MVD)与肿瘤生物学行为之间的关系。
6) blood density
血液密度
1.
The application of blood density me asurement in basic and clinical medicine is discussed in details.
本文介绍了血液密度测量的主要方法及面临的主要问题 ,并详细讨论了血液密度测量技术在基础医学和临床中的应
补充资料:非密度制约因素(见密度制约因素)
非密度制约因素(见密度制约因素)
l焦非密度制约因素见生态因素、密度制约后
说明:补充资料仅用于学习参考,请勿用于其它任何用途。
参考词条